Literature DB >> 25604614

Performance of different imaging modalities in assessment of response to neoadjuvant therapy in primary esophageal cancer.

C Yip1,2, G J R Cook1, D B Landau1,3, A Davies4, V Goh1,5.   

Abstract

Entities:  

Keywords:  esophageal cancer; imaging; neoadjuvant therapy; response

Mesh：

Substances：

Year:  2015        PMID： 25604614     DOI： 10.1111/dote.12315

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN： 1120-8694            Impact factor:   3.429


× No keyword cloud information.
  7 in total

Review 1.  Does radiomics play a role in the diagnosis, staging and re-staging of gastroesophageal junction adenocarcinoma?

Authors:  Martina Mori; Diego Palumbo; Francesco De Cobelli; Claudio Fiorino
Journal:  Updates Surg       Date:  2022-09-17

2.  Added value of MRI to endoscopic and endosonographic response assessment after neoadjuvant chemoradiotherapy in oesophageal cancer.

Authors:  Sophie E Vollenbrock; Jolanda M van Dieren; Francine E M Voncken; Sietze T van Turenhout; Liudmila L Kodach; Koen J Hartemink; Johanna W van Sandick; Berthe M P Aleman; Regina G H Beets-Tan; Annemarieke Bartels-Rutten
Journal:  Eur Radiol       Date:  2020-01-21       Impact factor: 5.315

3.  Preoperative Prediction of Pathologic Response to Neoadjuvant Chemoradiotherapy in Patients With Esophageal Cancer Using 18F-FDG PET/CT and DW-MRI: A Prospective Multicenter Study.

Authors:  Alicia S Borggreve; Lucas Goense; Peter S N van Rossum; Sophie E Heethuis; Richard van Hillegersberg; Jan J W Lagendijk; Marnix G E H Lam; Astrid L H M W van Lier; Stella Mook; Jelle P Ruurda; Marco van Vulpen; Francine E M Voncken; Berthe M P Aleman; Annemarieke Bartels-Rutten; Jingfei Ma; Penny Fang; Benjamin C Musall; Steven H Lin; Gert J Meijer
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-01-25       Impact factor: 7.038

Review 4.  New frontiers in esophageal radiology.

Authors:  Eric J Schmidlin; Ritu R Gill
Journal:  Ann Transl Med       Date:  2021-05

5.  Diagnostic performance of MRI for assessment of response to neoadjuvant chemoradiotherapy in oesophageal cancer.

Authors:  S E Vollenbrock; F E M Voncken; J M van Dieren; D M J Lambregts; M Maas; G J Meijer; L Goense; S Mook; K J Hartemink; P Snaebjornsson; L C Ter Beek; M Verheij; B M P Aleman; R G H Beets-Tan; A Bartels-Rutten
Journal:  Br J Surg       Date:  2019-02-25       Impact factor: 6.939

6.  Preoperative image-guided identification of response to neoadjuvant chemoradiotherapy in esophageal cancer (PRIDE): a multicenter observational study.

Authors:  A S Borggreve; S Mook; M Verheij; V E M Mul; J J Bergman; A Bartels-Rutten; L C Ter Beek; R G H Beets-Tan; R J Bennink; M I van Berge Henegouwen; L A A Brosens; I L Defize; J M van Dieren; H Dijkstra; R van Hillegersberg; M C Hulshof; H W M van Laarhoven; M G E H Lam; A L H M W van Lier; C T Muijs; W B Nagengast; A J Nederveen; W Noordzij; J T M Plukker; P S N van Rossum; J P Ruurda; J W van Sandick; B L A M Weusten; F E M Voncken; D Yakar; G J Meijer
Journal:  BMC Cancer       Date:  2018-10-20       Impact factor: 4.430

7.  Prediction of a positive circumferential resection margin at surgery following neoadjuvant chemotherapy for adenocarcinoma of the oesophagus.

Authors:  W R C Knight; C Yip; W Wulaningsih; A Jacques; N Griffin; J Zylstra; M Van Hemelrijck; N Maisey; A Gaya; C R Baker; M Kelly; J A Gossage; J Lagergren; D Landau; V Goh; A R Davies; S Ngan; A Qureshi; H Deere; M Green; F Chang; U Mahadeva; B Gill-Barman; S George; J Dunn; S Zeki; J Meenan; O Hynes; G Tham; C Iezzi
Journal:  BJS Open       Date:  2019-08-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.